Comment Sweet Innocence (Score 1) 386
Comment Re:Nope (Score 1) 336
Comment Re:What's the point? (Score 0, Redundant) 853
Comment Re:Land? (Score 1) 218
Comment Re:Land? (Score 1) 218
Comment Re:Land? (Score 2, Interesting) 218
Comment Land? (Score 1) 218
Comment Re:Call the It Dept! (Score 1) 210
Comment Re:Perish the thought? (Score 1) 532
Comment Re:Gold cure sickness (Score 0, Flamebait) 97
Command and control economies lead to scarcity, a fact born out repeatedly in history. Extreme examples in today's world are Cuba, North Korea, and China. Anyway, you asked about rationing, I provided a paper that points out, "Measured in units per million, the United States experiences levels of availability up to three times greater than in Canada and Germany," for basic life saving technologies like open heart surgery and radiation therapy. Rather than foam at the mouth, perhaps you could provide evidence that refutes this?
Comment Re:Gold cure sickness (Score 1) 97
http://www.stockholm-network.org/downloads/publications/Health_Technology_Assessment_in_Context.pdf
Europe is burdened by its historical commitment to expanding entitlement with the result that HTA is increasingly performed with cost-containment in mind. Interest in HTA in Europe and Canada has increased because of the need to justify expenditure on technology, particularly where countries lack their own domestic pharmaceutical industry, and because the combined pressures of ageing populations and more demanding consumers are exerting cost pressures on governments at the very same moment as the tax base is shrinking or static.
Where consumers in the US have a wide range of drugs available to them European consumers are far more restricted in their choice. Although countries with nationalised health services believe that their healthcare systems prioritise the interest of citizens, HTA is in fact used as a precursor to supply-side restrictions on pricing and reimbursement.
Comment Re:Gold cure sickness (Score 1) 97
http://history1900s.about.com/library/misc/blnobelmed.htm
Here's a great analysis by the Heritage Foundation regarding where increased costs are coming from with regards to paying for health care:
http://www.heritage.org/Research/Reports/2010/02/Bending-the-Curve-What-Really-Drives-Health-Care-Spending
Here's a good paper that looks at research priorities in different countries, among other things:
http://www.stockholm-network.org/downloads/publications/Health_Technology_Assessment_in_Context.pdf
Among other things, they conclude:
Where consumers in the US have a wide range of drugs available to them European consumers are far more restricted in their choice. Although countries with nationalised health services believe that their healthcare systems prioritise the interest of citizens, HTA is in fact used as a precursor to supply-side restrictions on pricing and reimbursement.
Here are some other good articles:
http://www.heritage.org/Research/Reports/2009/02/Comparative-Effectiveness-in-Health-Care-Reform-Lessons-from-Abroad#_ftn32
http://www.adamsmith.org/publications/health/funding-uk-healthcare/
http://www.civitas.org.uk/pdf/hpcgSystems.pdf